Global Named Patients Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Named Patients Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Named Patients Program Today - Breaking & Trending Today

Ascentage Pharma Announces Phase I/II Data of Olverembatinib (HQP1351) Published in the Journal of Hematology & Oncology, Further Validating the Drug's Best-in-Class Potential

Published: September 21, 2022

/PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),...

Source: prnewswire.com

Related Topics:

United StatesHong KongQian JiangWestern AustraliaAscentage PharmaTanner PharmaYifan ZhaiXiaojun HuangMajor NationalInstitute Of HematologyMd Anderson Cancer CenterAmerican Society Of HematologyChina National Medical Products AdministrationNational Major New Drug DiscoveryDana Farber Cancer InstituteHematology Department At Peking University People HospitalChinese Society Of Clinical OncologyCancer AssociationNational Major New Drug DevelopmentGlobal Named Patients ProgramDrug AdministrationOncologist NetworkEuropean Medicines AgencyManufacturing ProgramImpact Factor